news
Researchers have revealed that the disruption of oligodendrocytes, which produce…
5 February 2020 | By Victoria Rees (Drug Target Review)
Researchers have revealed that the disruption of oligodendrocytes, which produce myelin, may be a cause of autism spectrum disorder, so presents a therapeutic target.